Jan­u­ary’s new drug price in­creas­es take off with­out over­com­pen­sat­ing for up­com­ing in­fla­tion-linked re­bates

Phar­ma’s an­nu­al price in­creas­es on drugs — the vast ma­jor­i­ty of which usu­al­ly oc­cur in Jan­u­ary of every year — didn’t no­tice­ably spike this year (so far) when com­pared to re­cent years, and ex­perts say it doesn’t seem like phar­ma is des­per­ate yet to make up for what may be ma­jor loss­es in sales thanks to gov­ern­ment ne­go­ti­a­tions for some high-earn­ing drugs come 2026.

An­a­lysts at 46Brook­lyn pub­lished their lat­est 450+ avail­able in­creas­es on list prices (not to be con­fused with the prices peo­ple pay out of pock­et), as of Jan. 1, find­ing that as with pre­vi­ous years, most of the in­creas­es re­mained at or be­low the in­dus­try bar of 10%, and a me­di­an price in­crease of 5% so far in 2023.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN